| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/12/2004 | US20040029882 Antimicrobial quinolones, their compositions and uses |
| 02/12/2004 | US20040029879 Viricides for herpes virus |
| 02/12/2004 | US20040029877 Immune response induction; viricides; anticancer agents |
| 02/12/2004 | US20040029870 Antiinflammatory agents |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029864 Synergistic mixture of cyclooxygenase inhibitor and active drug |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029838 Anticancer agents |
| 02/12/2004 | US20040029828 Homeostasis-maintaining agents |
| 02/12/2004 | US20040029817 Water solubility; fungicides |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics |
| 02/12/2004 | US20040029767 Disinfectant |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029251 Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture |
| 02/12/2004 | US20040029227 Prolonging expression of an exogenous gene in a cell transduced with the gene; for treatment of brain disorders like tumours, Alzheimer's disease, Parkinson's disease, lateral amyotrophic sclerosis, neurodegenerative disorders |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029127 Use of lactobacillus case in immunostimulatory peptides |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040028754 Use of phyllanthus component for the treatment or prophylaxis of infections triggered by flaviviridae |
| 02/12/2004 | US20040028748 Remedies for dermatophytosis |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028728 Liposome preparations |
| 02/12/2004 | US20040028727 Dry formulation for transcutaneous immunization |
| 02/12/2004 | US20040028701 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 02/12/2004 | US20040028698 Vaccine |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028672 Calibration of infection therapy measuring proteinase; antiulcer agents; wound healing agent |
| 02/12/2004 | US20040028663 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 02/12/2004 | US20040028653 Self-rearranging DNA vectors |
| 02/12/2004 | US20040028652 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040027537 Continuous two-dimensional corneal topography target |
| 02/12/2004 | US20040026237 Ionization device which is mounted with gold pole or silver pole |
| 02/12/2004 | US20040025876 Capsules for dry powder inhalers and methods of making and using same |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10234422A1 Antibakterielle Ester-Makrozyklen Antibacterial ester macrocycles |
| 02/12/2004 | DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors |
| 02/12/2004 | CA2495479A1 Antibacterial ester macrocycles |
| 02/12/2004 | CA2495447A1 Anti-microbial compositions and methods of using same |
| 02/12/2004 | CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | CA2494518A1 Novel crystalline forms of gatifloxacin |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | CA2494017A1 Delayed release anti-viral product, use and formulation thereof |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/11/2004 | EP1388347A1 Multilayered elastomer material containing a chemical active substance and applications thereof |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387850A2 Antiviral nucleosides |
| 02/11/2004 | EP1387844A1 Retinol derivatives potentiation of active substances by micellar preparation |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | EP1387841A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387837A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 02/11/2004 | EP1387694A2 Composition and method for treating cancer using herpes virus |
| 02/11/2004 | EP1387693A1 Saponin inactivated mycoplasma vaccine |
| 02/11/2004 | EP1387684A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| 02/11/2004 | EP1387681A2 Antiviral compounds |
| 02/11/2004 | EP1387660A1 Use of 3-position cyclosporin derivatives for hair growth |
| 02/11/2004 | EP1328282A4 Efficient method for producing compositions enriched in anthocyanins |
| 02/11/2004 | EP1224177B1 Process for preparing oxazolines from tetrahydrofurans |
| 02/11/2004 | EP1180033B1 Lamivudine containing pharmaceutical formulation |
| 02/11/2004 | EP1176962B1 Liposome compositions for improved drug retention |
| 02/11/2004 | EP1107776B1 Dry extract of henna, method for producing said extract and use of the same |
| 02/11/2004 | EP1079808B1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 02/11/2004 | EP0994716B1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | EP0892640B1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/11/2004 | EP0862615B1 Immunity against pasteurella haemolytica leukotoxin |
| 02/11/2004 | EP0835124B1 Serum preparations for inhibiting retroviruses and tumor growth |
| 02/11/2004 | EP0832094B1 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 02/11/2004 | EP0655072B1 Immunological method for the detection of antibodies to equine herpesvirus type 1 and 4 glycoprotein G |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1473853A Anti-bacteria endotoxin chicken ritellus antibody and its preparation and its use |
| 02/11/2004 | CN1473847A Glycosidase activity of Luffa acutangula, and its use |
| 02/11/2004 | CN1473620A Capsule of cordyceps |
| 02/11/2004 | CN1473604A Capsule for treating epidemic parotitis |
| 02/11/2004 | CN1473602A Extracting and preparing process for Echinacea prupurea and its products |
| 02/11/2004 | CN1473601A Chinese medicine compound preparation for preventing and inhibiting infectious bacteria and virus and its producing method |
| 02/11/2004 | CN1473596A Anti-cold oral drip-pill and preparing process |
| 02/11/2004 | CN1473586A Medicine-Zaofeng liquid for treating mycotic infection |
| 02/11/2004 | CN1473580A Composition of Chinese medicine |
| 02/11/2004 | CN1473577A Process for preparing special preparation for curing beriberi and smelly foot |
| 02/11/2004 | CN1473576A Sea-buckthorn whole fruit agent and its preparing method and use |